BackBioPlus Acquisition Overview

BioPlus Acquisition Common Stock

Latest common stock for BIOS: $140M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$138.43M
↓ 41.08% YoYΔ $-96.50M vs prior year quarter

Peer trimmed avg / median

Loading

BioPlus Acquisition Common Stock History

Loading

BioPlus Acquisition vs. peers: Common Stock Comparison

Loading

BioPlus Acquisition Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

BioPlus Acquisition (BIOS) FAQ

As of the most recent data (June 2023), BIOS shows a common stock of $140M. That compares with $230M in the prior-year period — down 41.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOS's common stock is now $140M (was $230M) — a 41.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioPlus Acquisition is outperforming or lagging.

Tracking BIOS's common stock over time shows whether BioPlus Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $140M That compares with $230M in the prior-year period — down 41.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has BioPlus Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $140M) with ownership activity and broader fundamentals.